(Total Views: 598)
Posted On: 04/02/2019 1:55:40 PM
Post# of 120
![Avatar](https://investorshangout.com/images/ProfileImages/411968592_59827_pY--nyLE_400x400.png)
$CLVS News Article - Clovis Oncology Announces Interim Results from Rubraca (rucaparib) Phase 2 Study in Advanced Pancreatic Cancer and Nonclinical Data in Multiple Solid Tumor Types for Rucaparib and Lucitanib Presented at AACR 2019 https://marketwirenews.com/news-releases/clov...32146.html
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)
My Twitter: WhyteStocks
Scroll down for more posts ▼